Investigation Report on China Fat Emulsion Market, 2010-2019
|出版商||China Research and Intelligence||商品編碼||338987|
|出版日期||內容資訊||英文 40 Pages
|脂肪乳劑的中國市場 Investigation Report on China Fat Emulsion Market, 2010-2019|
|出版日期: 2015年09月07日||內容資訊: 英文 40 Pages||
As an emulsion of soy bean oil, egg phospholipids and glycerin, fat emulsion injection provides essential fatty acids for people who are unable to get nutrition via an oral diet.
The concept of fat emulsion dated back to the 1960s when hospitals in advanced countries found soy bean oil with its oleic acid and linoleic acid to be an ideal component of intravenous nutrition for critically ill patients like those who suffer from serious burn or advanced tumor and dyscrasia or those who had car accident or major surgery. Ever since 1961 when Interlipid, a soybean oil fat emulsion injection, was developed by scientists with Fresenius Kabi (Sweden) Co., Ltd, it has remained the best-selling injection. In 1983, Sino-Swed Pharmaceutical Corp. Ltd introduced raw material and patented technology from Fresenius Kabi (Sweden) Co., Ltd to produce Interlipid. In the mid-1980s, such western giants as Fresenius Company developed medium- and long-chain fatty acid injection with fewer adverse effects which was included by the National Health and Family Planning Commission of the People's Republic of China into the national medicare drug list as early as a decade ago.
The wide application of fat emulsion has been limited by its high unit price of CNY 80 despite an annual sales volume of over 10 million in recent years. But with rising ability to pay and increasing incidence of such diseases as malignant cancer, cardiovascular diseases and respiratory diseases caused by environmental pollution and lifestyle changes, the demand for fat emulsion will keep going up.
According to CRI's market survey, the sales value of fat emulsion in sample hospitals rose from less than CNY 300 million in 2005 to over CNY 900 million in 2014 and CAGR during this period surpassed 14%.
As Chinese people's capability to pay rises, fat emulsion, a component of intravenous nutrition, with its wide application in clinical practice, has witnessed a growing market and therefore good market prospects.
Readers can get at least the following information through this report:
The author suggests the following groups of people purchase this report: